Logo Lantheus Holdings

Lantheus Holdings (LNTH) stock: analyst price target and their real reliability

Live quote · data updated Aug 28, 2026
Lantheus Holdings · Health Care · ref. ETF XLV · 57 calls · price $100.47
🔔Price alertsCreate an alert →
What the company does: Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in diagnosis and treatment of heart, cancer, and other diseases worldwide.

📈 Lantheus Holdings (LNTH) stock price

$100.47+81.0% over range
Aug 28, 25low $50.11 · high $110.94Aug 27, 26
📏 Click 2 points (left → right) to measure the change · click again to clear.
SellBuy
Hold
43% recommend buying · 7 analysts
📊 JPI status : Lantheus Holdings is no longer in our current JPI rankings, but appeared in the past (2024, 2023) — its upside may be behind it. See the stocks picked in 2024 →

🎯 LNTH price target & analyst consensusprice $100

The price target · all analysts combined (5 targets)
Highest target · 1 firm of 5$129+28.4%
Median target · of 5 targets$115+14.5%
Lowest target · 2 firms of 5$102.5+2.0%
Current price$100.47
Where these 5 targets sit · versus the current price · 1 target per firm, last 6 months
Above the price 5100% $103 ↔ $129
⭐ What the most reliable analysts say · those who beat their sector, targets replayed on real prices

⭐ The most reliable of them, either direction: Mizuho64% of its targets hit on this sector (70 calls tested). It aims for $115 (+15 %), call made on July 30, 2026, maturing on July 30, 2027 (29 d ago).

The 3 reliable analysts $103+2.0 %
The 2 other firms $122+21 %
How to read it: the 3 reliable firms are not filtered by optimism — 3 aim above the price, 0 below, hence their $103 median. “The 2 others” are the firms that don't pass our reliability filter on this sector.
The consensus · 7 ratings (last 6 months)
Strong Buy00%
Buy343%
Hold457%
Sell00%
Strong Sell00%
Go deeper on the analysts
All analysts (the consensus)  ·  vs  ·  the best (those who've been right)
💬 A question about Lantheus Holdings? The JPI assistant answers using our backtest data.

📈 Lantheus Holdings fundamentals: valuation, margins & growth › open the full page

P/E 24.1Net margin 17.7 %Revenue growth +2.7 %Average P/E

Revenue, net income and margin per year

Revenue Net income · hover a bar for details
2022
marg. 3 %
2023
Rev +39%Profit +1064%
2024
Rev +18%Profit −4%
2025
Rev +1%Profit −25%

🔎 Detailed analyses

✅ Historical analyst reliability on LNTH

Hit rate measured on targets already matured (12 months), replayed against real prices. Click a header to sort.

Firm % right i Gain vs sector i Calls i
SVB Leerink 88% +79.0% 8
B. Riley Securities  71% +30.4% 7
Mizuho  50% +25.7% 6
Jefferies  50% +19.2% 2
Truist Securities  50% +11.4% 14
JMP Securities 33% +3.2% 9

📊 What $1,000 invested in Lantheus Holdings would be worth › open the full page

In short — $1,000 invested in Lantheus Holdings 10 years ago would be worth $32,822 today, i.e. +42%/yr on average. Best year: 2016 (+154%), worst: 2020 (-34%). Price performance, excluding dividends.

If I'd invested $1,000 in Lantheus Holdings

InvestmentWorth todayGain
1 years ago$1,240+24%
3 years ago$2,177+118%
5 years ago$8,224+722%
→ See Lantheus Holdings's full return history + gain calculator

Return by year (Lantheus Holdings)

YearReturn$1,000 invested at year start
2026 (YTD)+67%$1,667 (+67%)
2025-26%$1,240 (+24%)
2024+44%$1,789 (+79%)
→ See Lantheus Holdings's full return history + gain calculator
⚠️ Past performance, not predictive nor advice. Prices in $, excluding dividends. Yahoo Finance data.

📰 Recent news on Lantheus Holdings

Loading news…

📋 All analyst calls on LNTH

■ Hold neutral · not a buy · 🎯$102.5
Price at call : $101.5 — gap to target +1%
Today : $100.47 — gap to target +2%
🎯 on LNTH : 58% (12 calls matureds) · 📊 on Health : 58.7% · +5.8% (109 calls)
in progress (365j)
matures : Aug 4, 27
■ Market Perform neutral · not a buy
🎯 on LNTH : no call matured yet · 📊 unranked overall
in progress (365j)
matures : Aug 4, 27
William Blair 
Aug 3, 26
■ Market Perform neutral · not a buy
🎯 on LNTH : no call matured yet · 📊 on Health : 50% · +37.8% (20 calls)
in progress (365j)
matures : Aug 3, 27
TD Cowen 
Aug 3, 26
■ Hold neutral · not a buy · 🎯$102.5
Price at call : $101.11 — gap to target +1%
Today : $100.47 — gap to target +2%
🎯 on LNTH : no call matured yet · 📊 on Health : 53.8% · +17.8% (26 calls)
in progress (365j)
matures : Aug 3, 27
Mizuho 
Jul 29, 26
▲ Outperform · 🎯$115
Price at call : $101 — upside +14%
Today : $100.47 — upside +14%
🎯 on LNTH : 100% (2 calls matureds) · 📊 on Health : 57.1% · +12.3% (70 calls)
in progress (365j)
matures : Jul 29, 27
▲ Buy · 🎯$125
Price at call : $107.59 — upside +16%
Today : $100.47 — upside +24%
🎯 on LNTH : 58% (12 calls matureds) · 📊 on Health : 58.7% · +5.8% (109 calls)
in progress (365j)
matures : Jul 16, 27
Mizuho 
Jul 15, 26
▲ Outperform · 🎯$120
Price at call : $105.11 — upside +14%
Today : $100.47 — upside +19%
🎯 on LNTH : 100% (2 calls matureds) · 📊 on Health : 57.1% · +12.3% (70 calls)
in progress (365j)
matures : Jul 15, 27
▲ Buy · 🎯$129
Price at call : $105.64 — upside +22%
Today : $100.47 — upside +28%
🎯 on LNTH : 71% (7 calls matureds) · 📊 on Health : 47.8% · +20.1% (23 calls)
in progress (365j)
matures : Jul 9, 27
See the other 49 calls, newest to oldest
Citizens
Jun 29, 26
▲ Market Outperform · 🎯$115
Price at call : $109.58 — upside +5%
Today : $100.47 — upside +14%
🎯 on LNTH : no call matured yet · 📊 unranked overall
in progress (365j)
matures : Jun 29, 27
Mizuho 
May 27, 26
▲ Outperform · 🎯$115
Price at call : $99.62 — upside +15%
Today : $100.47 — upside +14%
🎯 on LNTH : 100% (2 calls matureds) · 📊 on Health : 57.1% · +12.3% (70 calls)
in progress (365j)
matures : May 27, 27
▲ Buy · 🎯$115
Price at call : $96.23 — upside +20%
Today : $100.47 — upside +14%
🎯 on LNTH : 58% (12 calls matureds) · 📊 on Health : 58.7% · +5.8% (109 calls)
in progress (365j)
matures : May 11, 27
Citizens
May 8, 26
▲ Market Outperform · 🎯$115
Price at call : $94.07 — upside +22%
Today : $100.47 — upside +14%
🎯 on LNTH : no call matured yet · 📊 unranked overall
in progress (365j)
matures : May 8, 27
Mizuho 
May 8, 26
▲ Outperform · 🎯$100
Price at call : $93.06 — upside +7%
Today : $100.47 — upside -0%
🎯 on LNTH : 100% (2 calls matureds) · 📊 on Health : 57.1% · +12.3% (70 calls)
in progress (365j)
matures : May 8, 27
▲ Buy · 🎯$98
Price at call : $83.92 — upside +17%
Today : $100.47 — upside -2%
🎯 on LNTH : 58% (12 calls matureds) · 📊 on Health : 58.7% · +5.8% (109 calls)
in progress (365j)
matures : Apr 15, 27
Mizuho 
Apr 13, 26
▲ Outperform · 🎯$95
Price at call : $82.74 — upside +15%
Today : $100.47 — upside -5%
🎯 on LNTH : 100% (2 calls matureds) · 📊 on Health : 57.1% · +12.3% (70 calls)
in progress (365j)
matures : Apr 13, 27
▲ Buy · 🎯$89
Price at call : $76.3 — upside +17%
Today : $100.47 — upside -11%
🎯 on LNTH : 58% (12 calls matureds) · 📊 on Health : 58.7% · +5.8% (109 calls)
in progress (365j)
matures : Mar 2, 27
Mizuho 
Feb 27, 26
▲ Outperform · 🎯$85
Price at call : $76.3 — upside +11%
Today : $100.47 — upside -15%
🎯 on LNTH : 100% (2 calls matureds) · 📊 on Health : 57.1% · +12.3% (70 calls)
in progress (365j)
matures : Feb 27, 27
Citizens
Feb 27, 26
▲ Market Outperform · 🎯$85
Price at call : $74.91 — upside +13%
Today : $100.47 — upside -15%
🎯 on LNTH : no call matured yet · 📊 unranked overall
in progress (365j)
matures : Feb 27, 27
Jones Trading
Feb 27, 26
■ Hold neutral · not a buy
🎯 on LNTH : 0% (1 call matured) · 📊 overall : 57.1% · -3.4% (7 calls)
in progress (365j)
matures : Feb 27, 27
Citizens
Feb 24, 26
▲ Market Outperform · 🎯$78
Price at call : $75.72 — upside +3%
Today : $100.47 — upside -22%
🎯 on LNTH : no call matured yet · 📊 unranked overall
in progress (365j)
matures : Feb 24, 27
▲ Buy · 🎯$82
Price at call : $65.92 — upside +24%
Today : $100.47 — upside -18%
🎯 on LNTH : 58% (12 calls matureds) · 📊 on Health : 58.7% · +5.8% (109 calls)
in progress (365j)
matures : Dec 18, 26
Mizuho 
Dec 17, 25
▲ Outperform · 🎯$72
Price at call : $65.24 — upside +10%
Today : $100.47 — upside -28%
🎯 on LNTH : 100% (2 calls matureds) · 📊 on Health : 57.1% · +12.3% (70 calls)
in progress (365j)
matures : Dec 17, 26
▲ Buy · 🎯$80
Price at call : $66.57 — upside +20%
Today : $100.47 — upside -20%
🎯 on LNTH : 58% (12 calls matureds) · 📊 on Health : 58.7% · +5.8% (109 calls)
in progress (365j)
matures : Dec 12, 26
■ Hold neutral · not a buy · 🎯$61
Price at call : $53.37 — gap to target +14%
Today : $100.47 — gap to target -39%
🎯 on LNTH : 58% (12 calls matureds) · 📊 on Health : 58.7% · +5.8% (109 calls)
in progress (365j)
matures : Nov 10, 26
Goldman Sachs 
Oct 8, 25
■ Neutral neutral · not a buy · 🎯$77
Price at call : $52.39 — gap to target +47%
Today : $100.47 — gap to target -23%
🎯 on LNTH : 0% (1 call matured) · 📊 on Health : 57.9% · +13.8% (107 calls)
in progress (365j)
matures : Oct 8, 26
▲ Buy · 🎯$84
Price at call : $50.84 — upside +65%
Today : $100.47 — upside -16%
🎯 on LNTH : 71% (7 calls matureds) · 📊 on Health : 47.8% · +20.1% (23 calls)
in progress (365j)
matures : Sep 16, 26
TD Cowen 
Sep 15, 25
▲ Buy · 🎯$80
Price at call : $51.98 — upside +54%
Today : $100.47 — upside -20%
🎯 on LNTH : no call matured yet · 📊 on Health : 53.8% · +17.8% (26 calls)
in progress (365j)
matures : Sep 15, 26
■ Hold neutral · not a buy · 🎯$63
Price at call : $53.9 — gap to target +17%
Today : $100.47 — gap to target -37%
🎯 on LNTH : 58% (12 calls matureds) · 📊 on Health : 58.7% · +5.8% (109 calls)
in progress (365j)
matures : Aug 12, 26
▲ Market Outperform · 🎯$73
Price at call : $57.2 — upside +28%
Today : $100.47 — upside -27%
Expected +28% · Actual +77% · Reason (≥ +15%) : ✓ Yes
🎯 on LNTH : 25% (4 calls matureds) · 📊 unranked overall
+76.5%
stock +77% · XLV +29%
matured Aug 7, 26
Mizuho 
Aug 7, 25
▲ Outperform · 🎯$70
Price at call : $54.86 — upside +28%
Today : $100.47 — upside -30%
Expected +28% · Actual +84% · Reason (≥ +15%) : ✓ Yes
🎯 on LNTH : 100% (2 calls matureds) · 📊 on Health : 57.1% · +12.3% (70 calls)
+84.0%
stock +84% · XLV +28%
matured Aug 7, 26
▲ Buy · 🎯$109
Price at call : $80.95 — upside +35%
Today : $100.47 — upside +8%
Expected +35% · Actual +30% · Reason (≥ +15%) : ✓ Yes
🎯 on LNTH : 71% (7 calls matureds) · 📊 on Health : 47.8% · +20.1% (23 calls)
+29.5%
stock +30% · XLV +15%
matured Jun 23, 26
▲ Buy · 🎯$117
Price at call : $81.74 — upside +43%
Today : $100.47 — upside +16%
Expected +43% · Actual +15% · Reason (≥ +15%) : ✓ Yes
🎯 on LNTH : 58% (12 calls matureds) · 📊 on Health : 58.7% · +5.8% (109 calls)
+15.1%
stock +15% · XLV +8%
matured May 8, 26
▲ Buy · 🎯$122
Price at call : $97.71 — upside +25%
Today : $100.47 — upside +21%
Expected +25% · Actual -23% · Reason (≥ +15%) : ✗ No
🎯 on LNTH : 71% (7 calls matureds) · 📊 on Health : 47.8% · +20.1% (23 calls)
-22.5%
stock -23% · XLV -1%
matured Mar 21, 26
▲ Buy · 🎯$127
Price at call : $93.82 — upside +35%
Today : $100.47 — upside +26%
Expected +35% · Actual -19% · Reason (≥ +15%) : ✗ No
🎯 on LNTH : 58% (12 calls matureds) · 📊 on Health : 58.7% · +5.8% (109 calls)
-18.7%
stock -19% · XLV +6%
matured Feb 27, 26
JMP Securities
Jan 14, 25
▲ Market Outperform · 🎯$112
Price at call : $92.62 — upside +21%
Today : $100.47 — upside +11%
Expected +21% · Actual -29% · Reason (≥ +15%) : ✗ No
🎯 on LNTH : 25% (4 calls matureds) · 📊 unranked overall
-29.2%
stock -29% · XLV +13%
matured Jan 14, 26
Goldman Sachs 
Dec 18, 24
▲ Buy · 🎯$143
Price at call : $91.15 — upside +57%
Today : $100.47 — upside +42%
Expected +57% · Actual -29% · Reason (≥ +15%) : ✗ No
🎯 on LNTH : 0% (1 call matured) · 📊 on Health : 57.9% · +13.8% (107 calls)
-28.9%
stock -29% · XLV +12%
matured Dec 18, 25
▲ Buy · 🎯$120
Price at call : $84.08 — upside +43%
Today : $100.47 — upside +19%
Expected +43% · Actual -40% · Reason (≥ +15%) : ✗ No
🎯 on LNTH : 58% (12 calls matureds) · 📊 on Health : 58.7% · +5.8% (109 calls)
-39.7%
stock -40% · XLV -1%
matured Nov 8, 25
▲ Market Outperform · 🎯$112
Price at call : $87.5 — upside +28%
Today : $100.47 — upside +11%
Expected +28% · Actual -42% · Reason (≥ +15%) : ✗ No
🎯 on LNTH : 25% (4 calls matureds) · 📊 unranked overall
-42.1%
stock -42% · XLV -2%
matured Nov 7, 25
▲ Buy · 🎯$175
Price at call : $106.36 — upside +65%
Today : $100.47 — upside +74%
Expected +65% · Actual -49% · Reason (≥ +15%) : ✗ No
🎯 on LNTH : 0% (1 call matured) · 📊 unranked overall
-49.4%
stock -49% · XLV -12%
matured Sep 3, 25
▲ Market Outperform · 🎯$125
Price at call : $97.59 — upside +28%
Today : $100.47 — upside +24%
Expected +28% · Actual -27% · Reason (≥ +15%) : ✗ No
🎯 on LNTH : 25% (4 calls matureds) · 📊 unranked overall
-26.8%
stock -27% · XLV -12%
matured Aug 1, 25
▲ Buy · 🎯$135
Price at call : $98.62 — upside +37%
Today : $100.47 — upside +34%
Expected +37% · Actual -28% · Reason (≥ +15%) : ✗ No
🎯 on LNTH : 58% (12 calls matureds) · 📊 on Health : 58.7% · +5.8% (109 calls)
-28.4%
stock -28% · XLV -13%
matured Aug 1, 25
▲ Buy · 🎯$146
Price at call : $112.71 — upside +30%
Today : $100.47 — upside +45%
Expected +30% · Actual -36% · Reason (≥ +15%) : ✗ No
🎯 on LNTH : 71% (7 calls matureds) · 📊 on Health : 47.8% · +20.1% (23 calls)
-35.8%
stock -36% · XLV -10%
matured Jul 25, 25
Jones Trading
Jul 19, 24
▲ Buy · 🎯$137
Price at call : $116.79 — upside +17%
Today : $100.47 — upside +36%
Expected +17% · Actual -39% · Reason (≥ +15%) : ✗ No
🎯 on LNTH : 0% (1 call matured) · 📊 overall : 57.1% · -3.4% (7 calls)
-38.7%
stock -39% · XLV -11%
matured Jul 19, 25
▲ Buy · 🎯$141
Price at call : $123.62 — upside +14%
Today : $100.47 — upside +40%
Expected +14% · Actual -34% · Reason (≥ +15%) : ✗ No
🎯 on LNTH : 58% (12 calls matureds) · 📊 on Health : 58.7% · +5.8% (109 calls)
-34.2%
stock -34% · XLV -8%
matured Jul 11, 25
▲ Outperform · 🎯$127
Price at call : $123.62 — upside +3%
Today : $100.47 — upside +26%
Expected +3% · Actual -34% · Reason (≥ +15%) : ✗ No
🎯 on LNTH : 0% (1 call matured) · 📊 on Health : 54.5% · +10.0% (11 calls)
-34.2%
stock -34% · XLV -8%
matured Jul 11, 25
▲ Buy · 🎯$96
Price at call : $75.51 — upside +27%
Today : $100.47 — upside -4%
Expected +27% · Actual +43% · Reason (≥ +15%) : ✓ Yes
🎯 on LNTH : 58% (12 calls matureds) · 📊 on Health : 58.7% · +5.8% (109 calls)
+43.0%
stock +43% · XLV -2%
matured May 3, 25
Mizuho 
May 3, 24
▲ Buy · 🎯$100
Price at call : $75.53 — upside +32%
Today : $100.47 — upside -0%
Expected +32% · Actual +43% · Reason (≥ +15%) : ✓ Yes
🎯 on LNTH : 100% (2 calls matureds) · 📊 on Health : 57.1% · +12.3% (70 calls)
+43.0%
stock +43% · XLV -2%
matured May 3, 25
▲ Buy · 🎯$99
Price at call : $63.81 — upside +55%
Today : $100.47 — upside -1%
Expected +55% · Actual +58% · Reason (≥ +15%) : ✓ Yes
🎯 on LNTH : 71% (7 calls matureds) · 📊 on Health : 47.8% · +20.1% (23 calls)
+57.7%
stock +58% · XLV -5%
matured Apr 18, 25
▲ Buy · 🎯$82
Price at call : $68.14 — upside +20%
Today : $100.47 — upside -18%
Expected +20% · Actual +17% · Reason (≥ +15%) : ✓ Yes
🎯 on LNTH : 58% (12 calls matureds) · 📊 on Health : 58.7% · +5.8% (109 calls)
+17.5%
stock +17% · XLV +1%
matured Feb 25, 25
▲ Buy · 🎯$95
Price at call : $59.29 — upside +60%
Today : $100.47 — upside -5%
Expected +60% · Actual +62% · Reason (≥ +15%) : ✓ Yes
🎯 on LNTH : 71% (7 calls matureds) · 📊 on Health : 47.8% · +20.1% (23 calls)
+61.7%
stock +62% · XLV -1%
matured Jan 9, 25
▲ Buy · 🎯$110
Price at call : $68.39 — upside +61%
Today : $100.47 — upside +9%
Expected +61% · Actual +58% · Reason (≥ +15%) : ✓ Yes
🎯 on LNTH : 58% (12 calls matureds) · 📊 on Health : 58.7% · +5.8% (109 calls)
+57.6%
stock +58% · XLV +18%
matured Oct 3, 24
▲ Buy · 🎯$113
Price at call : $72.46 — upside +56%
Today : $100.47 — upside +12%
Expected +56% · Actual +47% · Reason (≥ +15%) : ✓ Yes
🎯 on LNTH : 71% (7 calls matureds) · 📊 on Health : 47.8% · +20.1% (23 calls)
+47.1%
stock +47% · XLV +18%
matured Oct 2, 24
▲ Buy · 🎯$110
Price at call : $69.48 — upside +58%
Today : $100.47 — upside +9%
Expected +58% · Actual +58% · Reason (≥ +15%) : ✓ Yes
🎯 on LNTH : 58% (12 calls matureds) · 📊 on Health : 58.7% · +5.8% (109 calls)
+58.0%
stock +58% · XLV +20%
matured Sep 27, 24
▲ Buy · 🎯$125
Price at call : $61.96 — upside +102%
Today : $100.47 — upside +24%
Expected +102% · Actual +75% · Reason (≥ +15%) : ✓ Yes
🎯 on LNTH : 58% (12 calls matureds) · 📊 on Health : 58.7% · +5.8% (109 calls)
+75.2%
stock +75% · XLV +19%
matured Sep 18, 24
▲ Buy · 🎯$125
Price at call : $64.1 — upside +95%
Today : $100.47 — upside +24%
Expected +95% · Actual +68% · Reason (≥ +15%) : ✓ Yes
🎯 on LNTH : 58% (12 calls matureds) · 📊 on Health : 58.7% · +5.8% (109 calls)
+67.7%
stock +68% · XLV +20%
matured Sep 14, 24
▲ Buy · 🎯$125
Price at call : $82.95 — upside +51%
Today : $100.47 — upside +24%
Expected +51% · Actual -3% · Reason (≥ +15%) : ✗ No
🎯 on LNTH : 58% (12 calls matureds) · 📊 on Health : 58.7% · +5.8% (109 calls)
-3.2%
stock -3% · XLV +11%
matured Jun 27, 24
▲ Buy · 🎯$91
Price at call : $55.54 — upside +64%
Today : $100.47 — upside -9%
Expected +64% · Actual +75% · Reason (≥ +15%) : ✓ Yes
🎯 on LNTH : 71% (7 calls matureds) · 📊 on Health : 47.8% · +20.1% (23 calls)
+75.2%
stock +75% · XLV +5%
matured May 9, 23

Frequently asked questions

Should I buy Lantheus Holdings stock?

This isn't buy advice. For Lantheus Holdings, the analyst consensus is "Hold", with an average price target of $115 (+14% vs the current price). What matters is their past reliability on this stock: the most reliable one is right 88% of the time (8 calls tracked on Lantheus Holdings). We show the numbers — you decide.

Is it too late to buy Lantheus Holdings? How high can it go?

The most bullish analyst target on Lantheus Holdings is $129 (+28% above today's price); the average is $115. That's the upside they see. Check how reliable those analysts have actually been on Lantheus Holdings on our site before trusting it.

Is Lantheus Holdings still a good buy?

The most useful "opinion" isn't an opinion — it's a track record: 6 analysts have a real record on Lantheus Holdings, the best hitting 88% over 8 calls. Current consensus: "Hold". Make your call on data, not noise.

Should you invest in Lantheus Holdings? The case for and against

The arguments for and against, one by one, from the numbers: why invest in LNTH (and why hesitate).

What has Lantheus Holdings's past performance been?

Historical returns and a "how much if I had invested" calculator: LNTH performance & returns.

Other Health stocks

Go further

JPI AI Analyst AI assistant · JPI Invest
Answers based on the tool’s data · not financial advice · full version (free)